Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
Financials
Financial year 2025
NeuroRX Dr Duprez from Kraainem, company number BE1002035239, closed financial year 2025 with a result of € 100,244 after tax. For that financial year NeuroRX Dr Duprez recorded a gross margin of € 144,731 and equity of € 122,808. Compared with financial year 2024, the result moved from € 19,459 to € 100,244. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 1, 2026.
€ 122,808
▲ € 100,244 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 100,244
▲ € 80,785 vs 2024
Profit after tax over the fiscal year.
€ 151,232
▲ € 137,624 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 114,808.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,409
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,247
▲ 290% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 47,321
▲ € 43,675 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -4,694 | € 24,603 | € 144,731 | ▲ € 120,128 |
| Profit after taxes | € -4,896 | € 19,459 | € 100,244 | ▲ € 80,785 |
| Equity | € 3,104 | € 22,564 | € 122,808 | ▲ € 100,244 |
| Total debts | € 6,916 | € 17,004 | € 68,757 | ▲ € 51,753 |
| Cash | € 3,779 | € 13,608 | € 151,232 | ▲ € 137,624 |
| Retained profit | € -4,896 | € 14,564 | € 114,808 | ▲ € 100,244 |
| Balance sheet total | € 10,021 | € 39,568 | € 191,565 | ▲ € 151,997 |
By gross margin, NeuroRX Dr Duprez ranks 7th of 13 companies with main activity “Activiteiten van medisch specialisten” in Kraainem that publish figures (fiscal year 2025).
Key figures of NeuroRX Dr Duprez, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about NeuroRX Dr Duprez the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to NeuroRX Dr Duprez?
What happened at NeuroRX Dr Duprez in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- New establishment in Kraainem. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 4,896 loss in 2023 to € 100,244 profit in 2025.
Paid € 43,761 in corporate taxes since 2023.
Best year ever: 2025, with € 100,244 profit.
Management
Behind NeuroRX Dr Duprez is THIERRY DUPREZ.
Directors
According to the 2025 annual accounts
THIERRY DUPREZ
Director
Establishments
Establishment units
Physical locations of this company
Grensstraat 195
1950 Kraainem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Kraainem
Same main activity (Activiteiten van medisch specialisten), 13 active companies in Kraainem, largest first.
€ 1.8 million gross margin · 2025
€ 516,267 gross margin · 2025
€ 319,990 gross margin · 2025
LAMBRECHT NOÉMIA, OPHTALMOLOGIE
€ 295,811 gross margin · 2025
€ 244,620 gross margin · 2025
€ 153,871 gross margin · 2022
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DUPREZ Thierry Philippe Jacques(oprichter) 100%
Details
- Company number
- 1002.035.239
- VAT number
- BE 1002.035.239
- Registered office
- Grensstraat 195, 1950 Kraainem
- Names & denominations
- NeuroRX Dr Duprez
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 November 2023
- Peppol
- Active · Active since 7 Sept 2026
- Contact
- [email protected]
- Activities · NACE
Activiteiten van medisch specialisten